Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
2004 StandoutScience
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404
2015
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
Recurrent BRAF mutations in Langerhans cell histiocytosis
2010 Standout
Oncogenic activation of the Notch1 gene by deletion of its promoter in Ikaros-deficient T-ALL
2010 StandoutNobel
Chromosome Abnormalities and Genetic Counseling
2011
Loss of T Cell and B Cell Quiescence Precedes the Onset of Microbial Flora-Dependent Wasting Disease and Intestinal Inflammation in Gimap5-Deficient Mice
2010 StandoutNobel
Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia
2002
The Hawthorne Effect: a randomised, controlled trial
2007 Standout
Cancer treatment and survivorship statistics, 2022
2022 Standout
Systemic lupus erythematosus in a boy with chronic granulomatous disease: Case report and review of the literature
1991
Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies
2012 Standout
Biology of Langerhans Cells and Langerhans Cell Histiocytosis
2006
No genomic aberrations in Langerhans cell histiocytosis as assessed by diverse molecular technologies
2008
Doxorubicin pathways
2010 Standout
Animal models of human disease: zebrafish swim into view
2007 Standout
Acute lymphoblastic leukaemia
2008
Guidelines for Identification of, Advocacy for, and Intervention in Neurocognitive Problems in Survivors of Childhood Cancer
2007
Perspectives on cancer therapy-induced mucosal injury
2004 Standout
Features of the dendritic cell lineage
2010 StandoutNobel
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
2012 Standout
Current management and challenges of malignant disease in the CNS in paediatric leukaemia
2008
Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk‐stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172)
2003
Childhood acute lymphoblastic leukaemia – current status and future perspectives
2001
Cell Sensitivity Assays: The MTT Assay
2011 Standout
Pulmonary Langerhans' Cell Histiocytosis
2001
NOTCH1-induced T-cell leukemia in transgenic zebrafish
2007
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2004
Different anthracycline derivates for reducing cardiotoxicity in cancer patients
2010
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Chronic Granulomatous Disease: Report on a National Registry of 368 Patients
2000 Standout
Pegaspargase: a review of clinical studies
2003
Outcome of treatment after first relapse in adults with acute lymphoblastic leukemia initially treated by the LALA-94 trial
2007
Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategies
2005
Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review
2004
From Krebs to clinic: glutamine metabolism to cancer therapy
2016 Standout
Estimating the optimal utilization rates of radiotherapy for hematologic malignancies from a review of the evidence
2005
Polymer conjugates as anticancer nanomedicines
2006 Standout
FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance
2003
Gut microbiota modulation of chemotherapy efficacy and toxicity
2017 Standout
Treatment of Acute Lymphoblastic Leukemia
2006
Unravelling the association of partial T-cell immunodeficiency and immune dysregulation
2008
Neurocognitive outcome in survivors of pediatric cancer
2010
Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour
2006
Cancer treatment and survivorship statistics, 2012
2012 Standout
Juvenile Xanthogranulomas in the First Two Decades of Life: A Clinicopathologic Study of 174 Cases With Cutaneous and Extracutaneous Manifestations
2003 Standout
Antibody Titers and Immune Response to Diphtheria-Tetanus-Pertussis and Measles-Mumps-Rubella Vaccination in Children Treated for Acute Lymphoblastic Leukemia
2005
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Natural compounds for cancer treatment and prevention
2009 Standout
PEGylation, successful approach to drug delivery
2005 Standout
Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell–macrophage lineage
2010
Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron
2009 Standout
Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997–2004)
2009
Health Supervision for Children With Down Syndrome
2011 Standout
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Lessons from the past: Opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies
2011
The histiocytoses: The fall of the Tower of Babel
1999
Childhood acute lymphoblastic leukemia
2002
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
1999 StandoutScience
Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia
1976
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Childhood and adolescent cancer statistics, 2014
2014 Standout
Classification of pediatric acute lymphoblastic leukemia by gene expression profiling
2003
CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS
1974
The family history of patients with primary or secondary antiphospholipid syndrome (APS)
2000
ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context
2012 Standout
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
2009 Standout
Attempts to demonstrate virus‐specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis
1976 StandoutNobel
Guidelines for the Primary Prevention of Stroke
2014 Standout
Weekly polyethylene glycol conjugated L-asparaginase compared with biweekly dosing produces superior induction remission rates in childhood relapsed acute lymphoblastic leukemia: a pediatric oncology group study
2000
SLAP Deficiency Enhances Number and Function of Regulatory T Cells Preventing Chronic Autoimmune Arthritis in SKG Mice
2011 StandoutNobel
The role of radiotherapy in cancer treatment
2005 Standout
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
2018 Standout
Cancer treatment and survivorship statistics, 2016
2016 Standout
Cancer treatment and survivorship statistics, 2019
2019 Standout
Intermediate-Dose Methotrexate and Intravenous 6-Mercaptopurine Chemotherapy for Children With Acute Lymphoblastic Leukemia Who Did Not Respond to Initial Induction Therapy
2002
A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
2006
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
2015 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Pharmacological and clinical evaluation of l-asparaginase in the treatment of leukemia
2006
Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital
2004
Results of consecutive trials for children newly diagnosed with acute myeloid leukemia from the Australian and New Zealand Children's Cancer Study Group
2002
Cancer treatment and survivorship statistics, 2014
2014 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of A Feldges being referenced
Systemic lupus erythematosus in Staphylococcus aureus hyperimmunoglobulinaemia E syndrome.
1983
Periodic Acid-Schiff Reaction, a Useful Index of Duration of Complete Remission in Acute Childhood Lymphocytic Leukemia
1974
Childhood NHL in Switzerland: Incidence and Survival of 120 Study and 42 Non‐Study Patients
1995
Constitutional Balanced Chromosomal Rearrangements and Neoplasm in Children
2001
Idarubicin improves blast cell clearance during induction therapy in children with AML: results of study AML-BFM 93
2001
Intellectual outcome in children and adolescents with acute lymphoblastic leukaemia treated with chemotherapy alone: age- and sex-related differences
2003
Coincidence of familial platelet glycoprotein Ib/IX deficiency (Bernard-Soulier syndrome), idiopathic autoantibody against platelet glycoprotein Ib/IX, familial appearence of antiphospholipid antibodies, and familial factor XII deficiency
1994
Cytogenetic abnormalities in Langerhans cell histiocytosis
1998
Treatment of relapsing acute lymphoblastic leukemia in childhood. I. Experiences with 82 first bone marrow and 17 isolated central nervous system relapses observed 1968-1980.
1987
Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group.
2000